Open App →
Back to News Feed
PR Newswire October 1, 2026 neutral

Renew Biotechnologies Enters Collaboration to Evaluate NeuroLens® in Multiple Sclerosis and Related Neuroimmunologic Diseases

Edge AI
<p>Cell-of-origin insights could deepen understanding of CNS injury and disease progression in multiple sclerosis and related diseases PLEASANT GROVE, Utah, Oct. 1, 2026 /PRNewswire/ -- Renew Biotechnologies today announced a clinical development collaboration with Mayo Clinic to evaluate...</p>
Read original article ↗

Related Articles

YYForce Deploys Hospitality Service Robot at Aloft by Marriott Langkawi Pantai Tengah in Malaysia

YY Circle Malaysia-branded robot brings the Company's human-and-robot workforce approach into a hotel operating environm

PR Newswire · October 1, 2026

SINTRONES impulsa la visión artificial con IA en VISION 2026

- SINTRONES impulsa la visión artificial con IA para la inspección de electrónica y semiconductores en VISION 2026 La co

PR Newswire · October 1, 2026

The People of Utah vs. Kevin O&#8217;Leary

On the morning of May 11th, the celebrity investor Kevin O’Leary appeared on Fox Business and announced that he was unde

The Verge · October 1, 2026

SINTRONES Powers AI Machine Vision for Electronics and Semiconductor Inspection at VISION 2026

High-bandwidth vision computing, patented phase-change liquid cooling, and multi-camera Edge AI accelerate real-time ins

PR Newswire · October 1, 2026